SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OmniCorder Technologies, Inc. (OMCT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RikRichter who wrote (47)10/24/2004 11:40:01 PM
From: Mahatmabenfoo   of 63
 
Well, now the result of all of OMCT's recent presentations to analysts has become clearer: closing price on 10/22/04 was $0.75.

All anyone had to do to understand this company is learn a little of its history. The fact it claims to have a product "FDA" approved becomes a bad thing when you realize it has no sales. When you realize made no sales for YEARS after FDA approval, and now has fewer than half the employees of a few years ago, you'd know this doggie is not on the way up.

But hey, they WERE able to give away a machine. At least someone took it for free.

- Charles

EAST SETAUKET, N.Y., Oct 14, 2004 (BUSINESS WIRE) -- OmniCorder Technologies, Inc. (OTCBB Symbol: OMCT) today announced the delivery of their new cancer therapy monitoring configuration of the BioScanIR(R) System to Italy's National Tumor Institute in Milan.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News